TherapeuticsMD Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for TherapeuticsMD, Inc. (TXMD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-2.18-7.70112.00-172.42-183.52-176.14-132.62
Depreciation & Amortization0.510.921.190.744.072.250.29
Stock Based Compensation0.261.2711.5718.1310.680.000.00
Change in Working Capital1.66-17.45-4.094.59-3.34-14.0016.36
Change in Accounts Receivable0.000.000.000.00-8.220.000.00
Change in Inventory0.000.000.00-0.71-3.340.000.00
Change in Accounts Payable0.23-2.14-1.21-1.061.890.000.00
Change in Other Working Capital1.43-0.13-2.885.656.330.000.00
Other Operating Activities-0.351.14-111.3293.838.7512.140.27
Net Cash from Operating Activities0.73-23.08-4.08-142.69-159.47-165.70-106.81
Investing Activities
Capital Expenditures0.000.00-0.36-0.03-0.213.89-0.22
Sales/Maturities of Investments0.000.00-0.36-2.19-1.39-20.020.00
Other Investing Activities0.000.00223.830.000.00-20.02-0.18
Net Cash from Investing Activities0.000.00223.48-2.22-1.60-23.91-21.50
Financing Activities
Debt Repayment0.000.00-219.43-50.000.00-81.660.00
Common Stock Issued0.003.152.47184.6731.9877.0389.91
Common Stock Repurchased0.000.00-38.660.000.000.000.00
Other Financing Activities0.000.00-1.27-5.12-1.250.00-3.79
Net Cash from Financing Activities0.003.15-235.21129.5580.73188.83162.79
Summary
Net Change in Cash0.73-44.99-15.81-15.36-80.34-0.7834.48
Cash at Beginning of Period4.3349.3265.1280.49160.83161.61127.14
Cash at End of Period5.06-25.6649.3265.1280.49160.83161.61
Free Cash Flow0.73-23.08-4.08-142.73-159.68-169.59-128.13
Supplemental Disclosures
Interest Paid0.000.0013.5525.0725.8517.791.89